CIK: 0001549738 · Show all filings
Period: Q1 2024 (← Previous) (Next →)
Filing Date: May 7, 2024
Total Value ($000): $273,746 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ESTA | ESTABLISHMENT LABS HLDGS INC | 3,192,485 | $162,497 | 59.4% | $24.59 | +63.2% | COM | G31249108 |
| CELH | CELSIUS HLDGS INC | 303,000 | $25,125 | 9.2% | $47.16 | +45.4% | COM NEW | 15118V207 |
| NVDA | NVIDIA CORPORATION | 26,425 | $23,877 | 8.7% | $47.22 | +53.4% | COM | 67066G104 |
| LLY | ELI LILLY & CO | 13,500 | $10,502 | 3.8% | $329.89 | +112.9% | COM | 532457108 |
| NVO | NOVO-NORDISK A S | 68,200 | $8,757 | 3.2% | $116.08 | — | ADR | 670100205 |
| MSOS | ADVISORSHARES TR | 872,283 | $8,732 | 3.2% | $7.60 | — | PURE US CANNABIS | 00768Y453 |
| COCO | VITA COCO CO INC | 345,621 | $8,444 | 3.1% | $26.69 | -13.0% | COM | 92846Q107 |
| ANF | ABERCROMBIE & FITCH CO | 65,090 | $8,158 | 3.0% | $90.98 | +25.3% | CL A | 002896207 |
| CPRX | CATALYST PHARMACEUTICALS INC | 413,392 | $6,589 | 2.4% | $15.40 | -2.1% | COM | 14888U101 |
| HRTX | HERON THERAPEUTICS INC | 2,292,418 | $6,350 | 2.3% | $1.75 | +43.3% | COM | 427746102 |
| IDR | IDAHO STRATEGIC RESOURCES | 271,697 | $2,299 | 0.8% | $8.30 | -14.4% | COM NEW | 645827205 |
| SNAP | SNAP INC | 170,000 | $1,952 | 0.7% | $12.26 | +9.3% | CL A | 83304A106 |
| GAME | GAMESQUARE HLDGS INC | 186,718 | $258 | 0.1% | $1.52 | 0.0% | COM | 36468G103 |
| HITI | HIGH TIDE INC | 102,144 | $207 | 0.1% | $1.45 | +23.6% | COM NEW | 42981E401 |